Mode
Text Size
Log in / Sign up
Phase 4 N=133 Randomized Double-blind Supportive Care

Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain

Prostate Disease · Malignancy · Benign Prostatic Hyperplasia · Prostate Cancer · Prostate Adenocarcinoma

Enrolled (actual)
133
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Post-biopsy Pain (VAS-P) — 1; 1 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Self-Administered Nitrous Oxide (Drug); Oxygen (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
Beth Israel Deaconess Medical Center
Primary completion
Sep 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Post-biopsy Pain (VAS-P)
1; 1
PRIMARY
Post-biopsy Anxiety (VAS-A)
0; 1
PRIMARY
Post-biopsy Anxiety Traits (STAI)
11; 12
SECONDARY
Time of Prostate Biopsy
10.6; 10.3
SECONDARY
Operator Assessment of "Tolerating Insertion of Rectal Probe"
2; 2
SECONDARY
Operator Assessment of "Patient Maintenance of Positioning"
2; 2
SECONDARY
Operator Assessment of "Patient Tolerance of Procedure"
2; 2

Summary

Transrectal prostate biopsy is a commonly performed ambulatory procedure for diagnosing prostate cancer. Prostate biopsy are associated with pain or anxiety. Nitrous oxide (or laughing gas) is a well-known inhaled anesthetic which is frequently used in dental offices and for pediatric procedures to alleviate a patient's anxiety and pain. This study seeks to determine whether administration of nitrous oxide at the time of prostate biopsy will improve a patient's experience of care.

Eligibility Criteria

Inclusion Criteria

  • Biological male
  • Aged 18 to 85 years
  • Scheduled for clinically-indicated prostate needle biopsy
  • Suitable for nitrous oxide/oxygen with willingness to be randomized to inhaled SANO or inhaled oxygen during the procedure
  • Access to an email and computer

Exclusion Criteria

  • Perioral facial hair impeding good mask seal
  • Learning disabilities and/or inability to cognitively complete survey questions
  • Taken a pre-procedure benzodiazepine or narcotic.
  • Has any of the following medical conditions:
  • Inner ear, bariatric or eye surgery within the last 2 weeks,
  • Current emphysematous blebs,
  • Severe B-12 deficiency.
  • Bleomycin chemotherapy within the past year.
  • Class III or higher heart failure.
  • Undergoing novel therapy for prostate cancer
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05803096). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search